Comparative analytical characterization of two commercial human follicle-stimulating hormones extracted from human urine

Current Medical Research and Opinion

Volumn 21, Issue 6, 2005, Pages 899-905

  Bassett, R ^a   Ceccarelli, D ^b   Crisci, C ^b   Di Tria, A M ^b   Mancinelli, M ^b   Martelli, F ^b   Mendola, D ^b   Pezzotti, A ^b  

^a Serono International SA   (Switzerland)

^b Industria Farmaceutica Serono SpA   (Italy)

Author keywords

Follicle stimulating hormone (FSH); Gonadotrophin; Highly purified u FSH; Human menopausal gonadotrophin (hMG); Urine derived fSH (u FSH)

Indexed keywords

FERTINORM P; FOLLITROPIN; FOLYRMON P; HUMAN MENOPAUSAL GONADOTROPIN; PROTEIN; UROFOLLITROPIN;

ANALYTIC METHOD; ARTICLE; BIOASSAY; COMPARATIVE STUDY; DRUG ACTIVITY; DRUG CONTAMINATION; DRUG FORMULATION; DRUG ISOLATION; DRUG MANUFACTURE; DRUG PURIFICATION; DRUG PURITY; DRUG QUALITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POSTMENOPAUSE; PROTEIN CONTENT; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; URINE;

FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; PHARMACEUTICAL PREPARATIONS; POSTMENOPAUSE;

EID: 21244440699     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079905X48410     Document Type: Article

References (10)

1. Lunenfeld B. Development of gonadotrophins for clinical use. Reprod Biomed Online 2002;4(Suppl 1):11-7
2. Ludwig M, Felberbaum RE, Diedrich K, Lunenfeld B. Ovarian stimulation: from basic science to clinical application. Reprod Biomed Online 2002;5(Suppl 1):73-86
3. Lunenfeld B. Treatment of anovulation by human gonadotropins. Int J Obstet Gynecol 1963;1:153-9
4. Rosenberg E, Coleman J, Damani M, Garcia CR. Clinical effect of post menopausal gonadotropin. Clin Endocrinol Metab 1962;23:181-9
5. Giudice E, Crisci C, Eshkol A, Papoian R. Composition of commercial gonadotrophin preparations extracted from human post-menopausal urine: characterization of non-gonadotrophin proteins. Hum Reprod 1994;9:2291-9
6. Li TC, Hindle JE. Adverse local reaction to intramuscular injections of urinary-derived gonadotrophins. Hum Reprod 1993;8:1835-6
7. Kauffman HF, Hovenga H, de Bruijn HW, Beintema JJ. Eosinophil derived neurotoxin (EDN) levels in commercial human urinary preparations of glycoprotein hormones. Eur J Obstet Gynecol Reprod Biol 1999;82:111-3
8. Van de Weijer BH, Mulders JW, Bos ES, Verhaert PD, van den Hooven HW. Compositional analyses of a human menopausal gonadotrophin preparation extracted from urine (menotropin). Identification of some of its major impurities. Reprod Biomed Online 2003;7:547-57
9. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-54
10. Steelman SL, Pohley FM. Assay of the follicle stimulating hormone based on the augmentation with human chorionic gonadotropin. Endocrinology 1953;53:604-16